Christopher T Su (Christopher Su)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Multiple Myeloma

Respiratory Syndrome Coronavirus

Radical Prostatectomy

Top Venues

JCO oncology practice

Leukemia & lymphoma

JCO precision oncology

Nature reviews. Clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Mengyang Di, Christopher T Su, Andrew J Cowan, Ajay K Gopal, Rahul Banerjee
Mitigating time toxicity in lymphoma and multiple myeloma. Leukemia & lymphoma (2024)
Christopher T Su, Jason C Chen, Jeremy B Sussman
Virtual care for multiple myeloma in the COVID-19 era: interrupted time series analysis of veterans health administration data. Leukemia & lymphoma (2023)
Christopher T Su, Veena Shankaran
Digital symptom assessment tools: the next frontier in financial toxicity screening. Nature reviews. Clinical oncology (2023)
Christopher T Su
Financial Toxicity Interventions in Hematologic Malignancies Are Timely and Necessary. JCO oncology practice 18 (9) (2022)
Christopher T Su, Emily Nizialek, Jacob E Berchuck, Panagiotis J Vlachostergios, Ryan Ashkar, Alexandra O Sokolova, Pedro C Barata, Rahul R Aggarwal, Rana R McKay, Neeraj Agarwal, Heather M McClure, Nellie N Nafissi, Alan H Bryce, A Oliver Sartor, Nicolas Sayegh, Heather H Cheng, Nabil Adra, Cora N Sternberg, Mary-Ellen Taplin, Marcin Cieslik, Ajjai S Alva, Emmanuel S Antonarakis
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer. The Prostate (2022)
Christopher T Su, Christine M Veenstra, Minal R Patel
Divergent Patterns in Care Utilization and Financial Distress between Patients with Blood Cancers and Solid Tumors: A National Health Interview Survey Study, 2014-2020. Cancers 14 (7) (2022)
Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch, Chih-Yuan Hsu, Yu Shyr, Shailesh Advani, Ruben A Mesa, Sanjay Mishra, Daniel P Mundt, Dimpy P Shah, R Alejandro Sica, Keith E Stockerl-Goldstein, Catherine S M Stratton, Matthias Weiss, Alicia Beeghly-Fadiel, Melissa K Accordino, Sarit E Assouline, Joy Awosika, Ziad Bakouny, Babar Bashir, Stephanie A Berg, Mehmet Asim Bilen, Cecilia A Castellano, Jacob C Cogan, Devendra Kc, Christopher R Friese, Shilpa Gupta, Daniel Hausrath, Clara Hwang, Nathalie A Johnson, Monika Joshi, Anup Kasi Loknath Kumar, Elizabeth J Klein, Vadim S Koshkin, Nicole M Kuderer, Daniel H Kwon, Chris Labaki, Tahir Latif, Eric K C Lau, Xuanyi Li, Gary H Lyman, Rana R McKay, Gayathri Nagaraj, Amanda Nizam, Taylor K Nonato, Adam J Olszewski, Hyma V Polimera, Andrew Jay Portuguese, Matthew M Puc, Pedram Razavi, Rachel Rosovski, Andrew L Schmidt, Sumit A Shah, Aditi Shastri, Christopher T Su, Pallawi Torka, Trisha Michel Wise-Draper, Leyre Zubiri, Jeremy L Warner, Michael A Thompson, null null
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19. Blood cancer discovery 3 (3) (2022)
Christopher T Su, Dolorence Okullo, Stephanie Hingtgen, Deborah A Levine, Susan Dorr Goold
Affordable Care Act and Cancer Survivors' Financial Barriers to Care: Analysis of the National Health Interview Survey, 2009-2018. JCO oncology practice 17 (10) (2021)
Vadim S Koshkin, Nicholas Henderson, Marihella James, Divya Natesan, Dory Freeman, Amanda Nizam, Christopher T Su, Ali Raza Khaki, Chelsea K Osterman, Michael J Glover, Ryan Chiang, Dimitrios Makrakis, Rafee Talukder, Emily Lemke, T Anders Olsen, Jayanshu Jain, Albert Jang, Alicia Ali, Tanya Jindal, Jonathan Chou, Terence W Friedlander, Christopher Hoimes, Arnab Basu, Yousef Zakharia, Pedro C Barata, Mehmet A Bilen, Hamid Emamekhoo, Nancy B Davis, Sumit A Shah, Matthew I Milowsky, Shilpa Gupta, Matthew T Campbell, Petros D Grivas, Guru P Sonpavde, Deepak Kilari, Ajjai S Alva
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study. Cancer (2021)
Fadi Taza, Albert E Holler, Wei Fu, Hao Wang, Nabil Adra, Costantine Albany, Ryan Ashkar, Heather H Cheng, Alexandra O Sokolova, Archana M Agarwal, Adam Kessel, Alan H Bryce, Nellie Nafissi, Pedro C Barata, A Oliver Sartor, Diogo Assed Bastos, Oren Smaletz, Jacob E Berchuck, Mary-Ellen Taplin, Rahul R Aggarwal, Cora N Sternberg, Panagiotis J Vlachostergios, Ajjai S Alva, Christopher T Su, Catherine Handy Marshall, Emmanuel S Antonarakis
Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 5 (2021)